Polymorphisms in the genes involved in the arachidonic acid‐pathway, fish consumption and the risk of colorectal cancer

No abstract is available for this paper.

• Publication year

  2006

• Venue

  International Journal of Cancer

• Publication date

  2006-07-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.21858PMID 16482563
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The PPAR{gamma} Pro12Ala polymorphism and risk for incident sporadic colorectal adenomas.

  2005cited by this paper
• PTGS2 (COX-2) −765G > C Promoter Variant Reduces Risk of Colorectal Adenoma among Nonusers of Nonsteroidal Anti-inflammatory Drugs

  2005cited by this paper
• Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition.

  2005cited by this paper
• Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer.

  2005cited by this paper
• Genome-wide association studies for common diseases and complex traits

  2005cited by this paper
• A common polymorphism in the 3'UTR of cyclooxygenase 2/prostaglandin synthase 2 gene and risk of lung cancer in a Chinese population.

  2005cited by this paper
• [International HapMap project].

  2005cited by this paper
• Peroxisome Proliferator-activated Receptor γ Activation Can Regulate β-Catenin Levels via a Proteasome-mediated and Adenomatous Polyposis Coli-independent Pathway*

  2004cited by this paper
• COX-2 gene promoter haplotypes and prostate cancer risk.

  2004cited by this paper
• The PPARγ Pro12Ala polymorphism and risk for incident sporadic colorectal adenomas

  2004cited by this paper
• Interaction between cyclooxygenase-2 gene polymorphism and dietary n-6 polyunsaturated fatty acids on colon cancer risk: The Singapore Chinese Health Study

  2004cited by this paper
• Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-κB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation

  2004cited by this paper
• Prostaglandin E2 promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor δ

  2004cited by this paper
• A polymorphism in the cyclooxygenase 2 gene as an inherited protective factor against myocardial infarction and stroke.

  2004cited by this paper
• A functional polymorphism in the promoter region of the cyclooxygenase‐2 gene is not associated with asthma and atopy in an Australian population

  2004cited by this paper
• Peroxisome-proliferator-activated receptors and cancers: complex stories

  2004cited by this paper
• Prostaglandin E(2) promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor delta.

  2004cited by this paper
• n-3 polyunsaturated fatty acids and colon cancer prevention.

  2004cited by this paper
• Peroxisome proliferator-activated receptor gamma activation can regulate beta-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway.

  2004cited by this paper
• Colorectal adenoma risk is modified by the interplay between polymorphisms in arachidonic acid pathway genes and fish consumption.

  2004cited by this paper
• Polymorphisms in prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) and risk of colorectal cancer

  2004influential reference
• Minimal haplotype tagging

  2003cited by this paper
• Arachidonic acid and colorectal carcinogenesis

  2003cited by this paper
• The International HapMap Project

  2003cited by this paper
• A prospective study of intake of fish and marine fatty acids and prostate cancer.

  2003cited by this paper
• Inverse association between phospholipase A2 and COX-2 expression during mouse colon tumorigenesis.

  2003cited by this paper
• Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer.

  2003cited by this paper
• Tissue levels of fish fatty acids and risk of colorectal adenomas: a case–control study (Netherlands)

  2003cited by this paper
• Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer.

  2003cited by this paper
• A method for the assessment of disease associations with single-nucleotide polymorphism haplotypes and environmental variables in case-control studies.

  2003cited by this paper
• The International HapMap Consortium. The International HapMap Project (Co-PI of Hong Kong Centre which responsible for 2.5% of genome)

  2003cited by this paper
• Controversy: PPARgamma as a target for treatment of colorectal cancer.

  2002cited by this paper
• Cyclooxygenase 1 (COX1) polymorphisms in African‐American and caucasian populations

  2002cited by this paper
• Prostaglandin H synthase 2 variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia.

  2002cited by this paper
• Quality and quantity of DNA isolated from frozen urine in population-based research.

  2002cited by this paper
• APC-dependent suppression of colon carcinogenesis by PPARγ

  2002cited by this paper
• Common Promoter Variant in Cyclooxygenase-2 Represses Gene Expression: Evidence of Role in Acute-Phase Inflammatory Response

  2002cited by this paper
• The importance of the ratio of omega-6/omega-3 essential fatty acids.

  2002cited by this paper
• Genetic analysis of case/control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease.

  2001cited by this paper
• Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers.

  1999cited by this paper
• Dietary polyunsaturated fatty acids and cancers of the breast and colorectum: emerging evidence for their role as risk modifiers.

  1999cited by this paper
• Colorectal cancer: molecules and populations.

  1999cited by this paper
• Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention.

  1996cited by this paper
• The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.

  1996cited by this paper
• The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia.

  1995cited by this paper
• High-yield noninvasive human genomic DNA isolation method for genetic studies in geographically dispersed families and populations.

  1995cited by this paper
• The DOM project for the early detection of breast cancer, Utrecht, The Netherlands.

  1984cited by this paper
• Nederland

  1972cited by this paper
• Calculator

  1932cited by this paper

• Interactions of Colorectal Cancer, Dietary Fats, and Polymorphisms of Arachidonate Lipoxygenase and Cyclooxygenase Genes: A Literature Review

  2022cites this paper
• Multi-Omics Approach Points to the Importance of Oxylipins Metabolism in Early-Stage Breast Cancer

  2022cites this paper
• Fish Consumption and Colorectal Cancer Risk: Meta-Analysis of Prospective Epidemiological Studies and Review of Evidence from Animal Studies

  2022cites this paper
• Peroxisome Proliferator-Activated Receptor Gamma Pro12Ala/C161T Genotypes and Risky Haplotype Altering Risk of Breast Cancer: A Turkish Case–Control Study

  2021cites this paper
• COX-2 gene rs689466 polymorphism is associated with increased risk of colorectal cancer among Caucasians: a meta-analysis

  2020cites this paper
• COX-2 gene rs689466 polymorphisms associated with increased risk of colorectal cancer among Caucasians

  2020cites this paper
• Dynamic Connectivity Alteration Facilitates Cognitive Decline in Alzheimer's Disease Spectrum

  2020cites this paper
• High consumption of fish tends to be inversely associated with the risk of colorectal cancer.

  2020cites this paper
• MicroRNA‐binding site polymorphisms and risk of colorectal cancer: A systematic review and meta‐analysis

  2019cites this paper
• PPARG rs3856806 C>T Polymorphism Increased the Risk of Colorectal Cancer: A Case-Control Study in Eastern Chinese Han Population

  2019cites this paper
• Association between cyclooxygenase-2 (COX-2) 8473 T > C polymorphism and cancer risk: a meta-analysis and trial sequential analysis

  2018cites this paper
• Single nucleotide polymorphism rs4648298 in miRNAs hsa-miR21 and hsa-miR590 binding site of COX gene is a strong colorectal cancer determinant.

  2018cites this paper
• Association between COX-2 -1195G>A polymorphism and gastrointestinal cancer risk: A meta-analysis

  2017cites this paper
• Association of PPARG rs 1801282 C>G polymorphism with risk of colorectal cancer: from a case-control study to a meta-analysis

  2017cites this paper
• PPARG c.1347C>T polymorphism is associated with cancer susceptibility: from a case-control study to a meta-analysis

  2017influential citation
• Cyclooxygenase-2 gene polymorphisms and susceptibility to colorectal cancer in a Brazilian population.

  2017cites this paper
• rs2910164 Polymorphism Confers a Decreased Risk for Pulmonary Hypertension by Compromising the Processing of microRNA-146a

  2015cites this paper
• Cyclooxygenase-2 (COX2) gene polymorphisms and the risk of sporadic colorectal cancer and polyps among Jordanian population.

  2015cites this paper
• Peroxisome proliferator-activated receptor gamma (PPARG) rs1801282 C>G polymorphism is associated with cancer susceptibility in asians: an updated meta-analysis.

  2015cites this paper
• Cyclooxygenase-2 -1195G>A (rs689466) polymorphism and cancer susceptibility: an updated meta-analysis involving 50,672 subjects.

  2015cites this paper
• The genetic variant of COX-2 acts as a potential risk factor of colorectal cancer: evidence from a meta-analysis based on 13461 individuals

  2015influential citation
• Meta-Analysis of the Association between COX-2 Polymorphisms and Risk of Colorectal Cancer Based on Case–Control Studies

  2014cites this paper
• The prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/ COX2) rs5277 polymorphism does not influence risk of colorectal cancer in an Iranian population.

  2014influential citation
• Role of genetic polymorphisms in PTGS2 and HPGD in colorectal cancer development

  2013cites this paper
• Polymorphisms in arachidonic acid metabolism-related genes and the risk and prognosis of colorectal cancer

  2013cites this paper
• Cyclooxygenase-2 Polymorphisms and Susceptibility to Colorectal Cancer: A Meta-Analysis

  2013cites this paper
• An association between the PTGS2 rs5275 polymorphism and colorectal cancer risk in families with inherited non-syndromic predisposition

  2013cites this paper
• Epigenetic deregulation of the COX pathway in cancer.

  2012cites this paper
• Systematic meta-analyses and field synopsis of genetic association studies in colorectal cancer.

  2012cites this paper
• PTGS1, PTGS2, ALOX5, ALOX12, ALOX15, and FLAP SNPs: interaction with fatty acids in colon cancer and rectal cancer

  2012cites this paper
• Systematic review: diet–gene interactions and the risk of colorectal cancer

  2012cites this paper
• Polymorphic human prostaglandin H synthase-2 proteins and their interactions with cyclooxygenase substrates and inhibitors

  2011cites this paper
• Cyclooxygenase‐2 (COX‐2) polymorphisms and risk of inflammatory bowel disease in a Scottish and Danish case–control study

  2011cites this paper
• The impact of common gene variants on the response of biomarkers of cardiovascular disease (CVD) risk to increased fish oil fatty acids intakes.

  2011cites this paper
• The Cox-2 -1195 G > A polymorphism and cancer risk: a meta-analysis of 25 case-control studies.

  2011cites this paper
• The Cox-2 2 1195 G > A polymorphism and cancer risk : a meta-analysis of 25 case – control studies

  2011cites this paper
• Potentially functional COX‐2 −1195G>A polymorphism increases the risk of digestive system cancers: A meta‐analysis

  2010cites this paper
• Peroxisome proliferator-activated receptor-gamma 34C>G polymorphism and colorectal cancer risk: a meta-analysis.

  2010cites this paper
• Polymorphisms in inflammatory pathway genes and their association with colorectal cancer risk

  2010cites this paper
• Polymorphisms in regulatory regions of Cyclooxygenase-2 gene and breast cancer risk in Brazilians: a case-control study

  2010cites this paper
• COX-2 polymorphisms and colorectal cancer risk: a strategy for chemoprevention

  2010cites this paper
• Background Review Paper on Total Fat, Fatty Acid Intake and Cancers

  2009cites this paper
• Genetic Variability in NSAID Targets and NSAID-Metabolizing Enzymes and Colorectal Neoplasia

  2009cites this paper
• Cyclooxygenase-2 Polymorphisms, Aspirin Treatment, and Risk for Colorectal Adenoma Recurrence—Data from a Randomized Clinical Trial

  2009cites this paper
• No association between cyclooxygenase-2 and uridine diphosphate glucuronosyltransferase 1A6 genetic polymorphisms and colon cancer risk.

  2009cites this paper
• Genetic polymorphisms in the cyclooxygenase-1 and cyclooxygenase-2 genes and risk of colorectal adenoma

  2009cites this paper
• Cyclooxygenase polymorphisms in gastric and colorectal carcinogenesis: are conclusive results available?

  2009cites this paper
• Assembly of Inflammation-Related Genes for Pathway-Focused Genetic Analysis

  2007cites this paper
• Review article: nutrition, obesity and colorectal cancer

  2007cites this paper